PMID: 15480987

Hirtz S, Gonska T, Seydewitz HH, Thomas J, Greiner P, Kuehr J, Brandis M, Eichler I, Rocha H, Lopes AI, Barreto C, Ramalho A, Amaral MD, Kunzelmann K, Mall M
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
Gastroenterology. 2004 Oct;127(4):1085-95., [PubMed]
Sentences
No. Mutations Sentence Comment
63 ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15480987:63:311
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 15480987:63:318
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:63:382
status: NEW
view ABCC7 p.Ser1159Phe details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:63:389
status: NEW
view ABCC7 p.Ser1159Phe details
Original recordings of the effects of cAMP-dependent (100 ␮mol/L IBMX and 1 ␮mol/L forskolin, basolateral) and cholinergic (100 ␮mol/L carbachol and CCH, basolateral) activation on Vte and Rte in rectal tissues from (A) a control subject, (B) a CF patient with no detectable Cl- secretion (R1162X/Q552X), and (C) a CF patient expressing residual Cl- secretion (S1159F/S1159F), as evidenced by lumen-negative Vte responses. Login to comment
78 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15480987:78:1497
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15480987:78:418
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15480987:78:644
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15480987:78:1668
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15480987:78:1710
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15480987:78:2018
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15480987:78:1135
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15480987:78:2011
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15480987:78:606
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15480987:78:1277
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15480987:78:387
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 15480987:78:1584
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Glu585*
X
ABCC7 p.Glu585* 15480987:78:725
status: NEW
view ABCC7 p.Glu585* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15480987:78:979
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15480987:78:1873
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 15480987:78:1753
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 15480987:78:1939
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 15480987:78:1946
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15480987:78:1097
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15480987:78:799
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Gln39*
X
ABCC7 p.Gln39* 15480987:78:548
status: NEW
view ABCC7 p.Gln39* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 15480987:78:394
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 15480987:78:1901
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 15480987:78:1795
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 15480987:78:1867
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15480987:78:1838
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 15480987:78:1625
status: NEW
view ABCC7 p.Val232Asp details
ABCC7 p.Ser108Phe
X
ABCC7 p.Ser108Phe 15480987:78:1455
status: NEW
view ABCC7 p.Ser108Phe details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:78:1974
status: NEW
view ABCC7 p.Ser1159Phe details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:78:1981
status: NEW
view ABCC7 p.Ser1159Phe details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 15480987:78:1015
status: NEW
view ABCC7 p.Ala561Glu details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 15480987:78:1202
status: NEW
view ABCC7 p.Ala561Glu details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 15480987:78:1208
status: NEW
view ABCC7 p.Ala561Glu details
ABCC7 p.Met1137Arg
X
ABCC7 p.Met1137Arg 15480987:78:1908
status: NEW
view ABCC7 p.Met1137Arg details
ABCC7 p.Gln637*
X
ABCC7 p.Gln637* 15480987:78:762
status: NEW
view ABCC7 p.Gln637* details
ABCC7 p.Ile148Asn
X
ABCC7 p.Ile148Asn 15480987:78:1283
status: NEW
view ABCC7 p.Ile148Asn details
Relationship Between the CFTR Genotype and Cl- Channel Function in Native Rectal Epithelia CFTR genotype Number of individuals Sweat Cl-concentration (mmol/L)a cAMP-mediated response Carbachol-induced plateau response or maximal lumen-negative response Isc-cAMP (␮A/cm2) Cl- secretion (% of control) Isc-carbachol (␮A/cm2) Cl- secretion (% of control) Cl- secretion absent R1162X/Q552X 1 71 17.1 0 0.7 0 W1282X/3121-2AϾG 1 112 1.9 0 0.6 0 1898 ϩ 1G Ͼ T/1609delCA 2b 114, 118 25.4, 13.4 0, 0 0, 0.7 0, 0 ⌬F508/Q39X 2b 127, 129 2.6, 4.4 0, 0 1.7, 3.7 0, 0 ⌬F508/G542X 1 102 29.0 0 6.6 0 ⌬F508/R553X 3 112, 102, 109 13.1, 4.5, 23.8 0, 0, 0 1.5, 4.4, 1.0 0, 0, 0 ⌬F508/E585X 1 115 1.4 0 1.1 0 ⌬F508/Q637X 1 100 2.9 0 1.2 0 ⌬F508/Y1092X 1 119 0.0 0 -0.3 0 ⌬F508/120del23c 1 72 20.1 0 3.3 0 ⌬F508/182delT 1 116 10.8 0 5.2 0 ⌬F508/3905insT 2 88, 96 8.4, 5.6 0, 0 2.3, -1.1 0, 1 ⌬F508/V520F 1 68 1.2 0 1.7 0 ⌬F508/A561E 3 113, 146, 100 17.0, 17.0, 16.0 0, 0, 0 2.1, 1.5, 3.7 0, 0, 0 ⌬F508/R1066C 1 138 0.0 0 0.0 0 ⌬F508/N1303K 3 100, 117, 94 1.7, 4.1, 1.5 0, 0, 0 -0.6, 2.2, 0.8 0, 0, 0 A561E/A561E 2 101, 116 6.6, 2.0 0, 0 7.3, 3.3 0, 0 Residual Cl- secretiond G542X/I148N 1 75 -50.1 54 -22.2 12 1898 ϩ 3A Ͼ G/1898 ϩ 3A Ͼ G 1 82 -36.8 39 -12.9 7 ⌬F508/3272-26A Ͼ G 1 116 -17.8 19 -27.2 14 ⌬F508/S108F 1 118 -15.8 17 -12.3 7 ⌬F508/R117H 1 90 -35.9 38 -207.7 109 ⌬F508/Y161Cc 1 44 -35.1 37 -45.9 25 ⌬F508/P205S 1 80 -23.3 25 -10.4 5 ⌬F508/V232D 1 120 -16.9 18 -26.9 14 ⌬F508/R334W 1 92 -22.1 23 -21.1 11 ⌬F508/R334W 1 101 -24.5 26 -37.4 20 ⌬F508/T338I 1 73 -44.4 47 -79.4 42 ⌬F508/G576A 1 40 -16.9 18 -115.5 61 ⌬F508/I1234V 1 113 -13.6 15 -8.6 5 G576A/G85E 1 95 -26.1 28 -61.6 32 F1052V/M1137R 1 47 -36.7 39 -146.6 77 M1101K/M1101K 1 94 -11.1 12 -4.8 3 S1159F/S1159F 1 67 -47.9 51 -38.7 21 N1303K/R334W 1 91 -30.3 32 -47.7 25 NOTE. CFTR Cl- channel function was determined in rectal epithelia from Cl- secretory responses induced by IBMX/forskolin (Isc-cAMP) and after co-activation with carbachol (Isc-carbachol). Login to comment
84 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15480987:84:37
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser108Phe
X
ABCC7 p.Ser108Phe 15480987:84:107
status: NEW
view ABCC7 p.Ser108Phe details
One patient had TG10-9T/TG11-5T with G542X/1148N; the second patient had TG10-9T/TG12-5T with ⌬F508/S108F. Login to comment
87 ABCC7 p.Tyr161Cys
X
ABCC7 p.Tyr161Cys 15480987:87:147
status: NEW
view ABCC7 p.Tyr161Cys details
By extensive genotyping, 2 disease-causing CFTR mutations were identified in all 45 CF patients studied, including 2 novel mutations (120del23 and Y161C). Login to comment
101 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15480987:101:221
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15480987:101:737
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15480987:101:663
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15480987:101:315
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15480987:101:239
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15480987:101:649
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15480987:101:719
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 15480987:101:279
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Glu585*
X
ABCC7 p.Glu585* 15480987:101:670
status: NEW
view ABCC7 p.Glu585* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15480987:101:158
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15480987:101:178
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 15480987:101:322
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 15480987:101:375
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15480987:101:195
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15480987:101:700
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Gln39*
X
ABCC7 p.Gln39* 15480987:101:631
status: NEW
view ABCC7 p.Gln39* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 15480987:101:656
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 15480987:101:367
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 15480987:101:340
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15480987:101:353
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 15480987:101:297
status: NEW
view ABCC7 p.Val232Asp details
ABCC7 p.Ser108Phe
X
ABCC7 p.Ser108Phe 15480987:101:214
status: NEW
view ABCC7 p.Ser108Phe details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:101:414
status: NEW
view ABCC7 p.Ser1159Phe details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 15480987:101:165
status: NEW
view ABCC7 p.Ala561Glu details
ABCC7 p.Met1137Arg
X
ABCC7 p.Met1137Arg 15480987:101:394
status: NEW
view ABCC7 p.Met1137Arg details
ABCC7 p.Gln637*
X
ABCC7 p.Gln637* 15480987:101:683
status: NEW
view ABCC7 p.Gln637* details
ABCC7 p.Ile148Asn
X
ABCC7 p.Ile148Asn 15480987:101:253
status: NEW
view ABCC7 p.Ile148Asn details
Functional Classification and Protein Location of CFTR Mutations Mutation type Severe mutations (protein location) Mild mutations (protein location) Missense V520F, A561E (NBD1) G85E (MSD1, TM1) R1066C (MSD2, CL4) S108F, R117H (MSD1, EL1) N1303K (NBD2) I148N, Y161Ca (MSD1, CL1) P205S (MSD1, TM3) V232D (MSD1, TM4) R334W, T338I (MSD1, TM6) G576A (NBD1) I1234V (NBD2) F1052V, M1101K (MSD2, CL4) M1137R (MSD2, TM12) S1159F (pre-NBD2) Splice 1898 ϩ 1G Ͼ T (R domain) 1898 ϩ 3A Ͼ G (R domain) 3121-2A Ͼ G (MSD2, TM9) 3272-26A Ͼ G (MSD2, TM10) Single amino acid deletion ⌬F508 (NBD1) Nonsense Q39X (N-terminus) G542X, Q552X, R553X, E585X (NBD1) Q637X (R domain) Y1092X (MSD2, CL4) R1162X (pre-NBD2) W1282X (NBD2) Frameshift 120del23a 182delT (N-terminus) 1609delCA (NBD1) 3905insT (NBD2) NOTE. Severe mutation, Cl- secretion absent; mild mutation, residual cAMP-mediated Cl- secretion. Login to comment
114 ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15480987:114:257
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 15480987:114:250
status: NEW
view ABCC7 p.Ala561Glu details
CFTR-mediated Cl- secretion was absent (or below the level of detection) in all CF patients compound heterozygous for class I and II mutations, including ⌬F508, nonsense, frameshift, and missense mutations that result in defective processing (A561E, R1066C, Table 3. Login to comment
122 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15480987:122:168
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15480987:122:175
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15480987:122:0
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 15480987:122:182
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Ser108Phe
X
ABCC7 p.Ser108Phe 15480987:122:161
status: NEW
view ABCC7 p.Ser108Phe details
N1303K).8,9,11,34 -36 Mutants that have been shown previously to form plasma membrane Cl- channels with altered single-channel properties in heterologous cells (S108F, R117H, R334W, F1052V)10,34,35,37 were associated with residual cAMP-mediated Cl- secretion of ϳ12%-54% of control rectal epithelia. Login to comment
123 ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 15480987:123:171
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 15480987:123:307
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 15480987:123:266
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Met1137Arg
X
ABCC7 p.Met1137Arg 15480987:123:178
status: NEW
view ABCC7 p.Met1137Arg details
Residual function also was observed for mutants, which are expected to form membrane Cl- channels that are reduced in number, either owing to improper protein maturation (P205S, M1137R) or owing to reduced levels of full-length CFTR messenger RNA (3272-26AϾG, G576A).32,38 - 40 The only exception was M1101K, which was reported as a loss of function mutation in heterologous cells34 and was associated with residual CFTR function in the 1 homozygous patient studied (Table 1). Login to comment
125 ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15480987:125:78
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 15480987:125:165
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15480987:125:172
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 15480987:125:158
status: NEW
view ABCC7 p.Val232Asp details
ABCC7 p.Ser1159Phe
X
ABCC7 p.Ser1159Phe 15480987:125:184
status: NEW
view ABCC7 p.Ser1159Phe details
ABCC7 p.Tyr161Cys
X
ABCC7 p.Tyr161Cys 15480987:125:151
status: NEW
view ABCC7 p.Tyr161Cys details
ABCC7 p.Ile148Asn
X
ABCC7 p.Ile148Asn 15480987:125:144
status: NEW
view ABCC7 p.Ile148Asn details
According to our functional data, 3121-2AϾG, 1898ϩ1GϾT, and V520F constitute severe mutations, whereas 1898ϩ3AϾG, I148N, Y161C, V232D, T338I, I1234V, and S1159F confer residual CFTR Cl- channel function (Table 1). Login to comment
127 ABCC7 p.Ser108Phe
X
ABCC7 p.Ser108Phe 15480987:127:328
status: NEW
view ABCC7 p.Ser108Phe details
ABCC7 p.Ile148Asn
X
ABCC7 p.Ile148Asn 15480987:127:338
status: NEW
view ABCC7 p.Ile148Asn details
Previous studies have shown that the 5T allele, especially in conjunction with a high number of adjacent TG repeats, results in enhanced skipping of exon 9 and thus decreased levels of CFTR protein.41,42 It is therefore possible that reduced posttranscriptional processing of messenger RNA transcripts from mild CFTR mutations (S108F and I148N) contributed to reduced CFTR-mediated Cl- secretion, and the disease phenotype observed in these patients. Login to comment